Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 286
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

A comparison of five common drug–drug interaction software programs regarding accuracy and comprehensiveness

Kheshti Raziyeh, Aalipour Mohammadsadegh, Namazi Soha

Year : 2016| Volume: 5| Issue : 4 | Page no: 257-263

   This article has been cited by
 
1 Die pharmakologische/pharmazeutische Visite in der Intensivmedizin
H. Hilgarth,M. Baehr,S. Kluge,C. König
Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Prevalence of drug–drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management
Audrey Bellesoeur,Ithar Gataa,Anne Jouinot,Sarah El Mershati,Anne-Catherine Piketty,Camille Tlemsani,David Balakirouchenane,Anthia Monribot,Michel Vidal,Rui Batista,Sixtine de Percin,Clémentine Villeminey,Jérôme Alexandre,François Goldwasser,Benoit Blanchet,Pascaline Boudou-Rouquette,Audrey Thomas-Schoemann
Cancer Chemotherapy and Pharmacology. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Management of drug-disease interactions: a best practice from the Netherlands
Maaike M. E. Diesveld,Suzanne de Klerk,Pieter Cornu,Dorothea Strobach,Katja Taxis,Sander D. Borgsteede
International Journal of Clinical Pharmacy. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Determination of potential drug–drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a retrospective observational study
Afraa Abbas, Samaher Al-Shaibi, Sowndramalingam Sankaralingam, Ahmed Awaisu, Vyas S. Kattezhathu, Supakit Wongwiwatthananukit, Yaw B. Owusu
International Journal of Clinical Pharmacy. 2021;
[Pubmed]  [Google Scholar] [DOI]
5 Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study
John E. Hughes,Veronica Russo,Caroline Walsh,Enrica Menditto,Kathleen Bennett,Caitriona Cahir
Drugs & Aging. 2021;
[Pubmed]  [Google Scholar] [DOI]
6 Differences in Information Accessed in a Pharmacologic Knowledge Base Using a Conversational Agent vs Traditional Search Methods
Anita M. Preininger,Bedda L. Rosario,Adam M. Buchold,Jeff Heiland,Nawshin Kutub,Bryan S. Bohanan,Brett South,Gretchen P. Jackson
International Journal of Medical Informatics. 2021; : 104530
[Pubmed]  [Google Scholar] [DOI]
7 The screening and evaluation of potential clinically significant HIV drug combinations against the SARS-CoV-2 virus
Draško Tomic,Davor Davidovic,Attila Marcel Szasz,Melinda Rezeli,Boris Pirkic,Jozsef Petrik,Vesna Bacic Vrca,Vladimir Jandel,Tomislav Lipic,Karolj Skala,Josip Mesaric,Marija Milkovic Periša,Zorislav Šojat,Branka Medved Rogina
Informatics in Medicine Unlocked. 2021; : 100529
[Pubmed]  [Google Scholar] [DOI]
8 Prescription patterns of direct oral anticoagulants and concomitant use of interacting medications in the Netherlands
R. E. Harskamp,J. C. L. Himmelreich,G. W. M. Wong,M. Teichert
Netherlands Heart Journal. 2021;
[Pubmed]  [Google Scholar] [DOI]
9 Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults
Matthew Sugidono,Mimi Lo,Rebecca Young,Kimberly Rosario,Yoonie Jung,Chiung-Yu Huang,Ying Sheng,Li-Wen Huang,Rebecca L. Olin
Transplantation and Cellular Therapy. 2021;
[Pubmed]  [Google Scholar] [DOI]
10 Bradyarrhythmias in Cardio-Oncology
Marta Fonseca, Evaline Cheng, Duc Do, Shouvik Haldar, Shelby Kutty, Eric H. Yang, Arjun K. Ghosh, Avirup Guha
South Asian Journal of Cancer. 2021;
[Pubmed]  [Google Scholar] [DOI]
11 Risk factors for potential drug–drug interactions in patients with myasthenia gravis
Dejan Z. Aleksic,Miloš N. Milosavljevic,Srdan M. Stefanovic,Andriana Bukonjic,Jovana Z. Milosavljevic,Slobodan M. Jankovic,Ivo Božovic,Stojan Peric,Dragana Lavrnic
Neurological Research. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
12 Prevalence and characteristics of drug-drug interactions among hospitalised patients in the Capital Region of Denmark
Hans Kristian Rĺket Pedersen, Anne Mette Skov Sřrensen, Astrid Blicher Schelde, Martin Erik Nyeland, Espen Jimenez-Solem
Adverse Drug Reaction Bulletin. 2021; Publish Ah
[Pubmed]  [Google Scholar] [DOI]
13 A Cross-Sectional Study on Single-Day Use of Proton Pump Inhibitors in Tertiary Care Hospitals of South India
Zabiuddin Ahad M,Alekhya Lavu,Maria Ansari,Raviraj Acharya V,Rajesh Vilakkathala
Hospital Pharmacy. 2021; 56(2): 109
[Pubmed]  [Google Scholar] [DOI]
14 Novel Drug Interaction index and Risk of Mortality in Older Patients With Atrial Fibrillation Receiving Non Vitamin K Oral Anticoagulants (NOEL Drug)
Ibrahim Ersoy
Clinical and Applied Thrombosis/Hemostasis. 2021; 27: 1076029621
[Pubmed]  [Google Scholar] [DOI]
15 Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics
John B Bossaer, Danielle Eskens, Austin Gardner
Journal of Oncology Pharmacy Practice. 2021; : 1078155220
[Pubmed]  [Google Scholar] [DOI]
16 Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis
Niklas Frahm, Melanie Peters, Jörg Bätzing, David Ellenberger, Manas K. Akmatov, Judith Haas, Paulus S. Rommer, Alexander Stahmann, Uwe K. Zettl, Jakob Holstiege
Therapeutic Advances in Neurological Disorders. 2021; 14: 1756286421
[Pubmed]  [Google Scholar] [DOI]
17 Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data
Levin Thomas, Sumit Raosaheb Birangal, Rajdeep Ray, Sonal Sekhar Miraj, Murali Munisamy, Muralidhar Varma, Chidananda Sanju S.V., Mithu Banerjee, Gautham G. Shenoy, Mahadev Rao
Therapeutic Advances in Drug Safety. 2021; 12: 2042098621
[Pubmed]  [Google Scholar] [DOI]
18 Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
Marwan Sheikh-Taha,Myriam Asmar
BMC Geriatrics. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
19 Potential drug-drug interactions with psychotropic drugs in paediatric inpatients: A cross-sectional study
Nadir Yalçin,Nesligül Özdemir,Halime Tuna Çak Esen,Sadriye Ebru Çengel Kültür,Kutay Demirkan
International Journal of Clinical Practice. 2021;
[Pubmed]  [Google Scholar] [DOI]
20 The prevalence of potential drug–drug interactions in adults with intellectual disability
M. McMahon,C. Hatton,D. L. Bowring,C. Hardy,N. J. Preston
Journal of Intellectual Disability Research. 2021;
[Pubmed]  [Google Scholar] [DOI]
21 Prevention and management of physical health conditions in adults with severe mental disorders: WHO recommendations
Petra C. Gronholm,Neerja Chowdhary,Corrado Barbui,Jayati Das-Munshi,Kavitha Kolappa,Graham Thornicroft,Maya Semrau,Tarun Dua
International Journal of Mental Health Systems. 2021; 15(1)
[Pubmed]  [Google Scholar] [DOI]
22 Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study
Zarka Akbar,Sundas Rehman,Asad Khan,Amjad Khan,Muhammad Atif,Nafees Ahmad
Journal of Pharmaceutical Policy and Practice. 2021; 14(1)
[Pubmed]  [Google Scholar] [DOI]
23 Potentially Inappropriate Medication and Associated Factors Among Older Patients with Chronic Coronary Syndrome at Hospital Discharge in Beijing, China
Mei Zhao,Jun-Xian Song,Fang-Fang Zheng,Lin Huang,Yu-Fei Feng
Clinical Interventions in Aging. 2021; Volume 16: 1047
[Pubmed]  [Google Scholar] [DOI]
24 Polypharmacy and Potential Drug–Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study
Monica Hermann,Nina Carstens,Lars Kvinge,Astrid Fjell,Marianne Wennersberg,Kjersti Folleso,Knut Skaug,Ake Seiger,Berit Seiger Cronfalk,Anne-Marie Bostrom
Journal of Multidisciplinary Healthcare. 2021; Volume 14: 589
[Pubmed]  [Google Scholar] [DOI]
25 Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson’s Disease
Niklas Frahm,Michael Hecker,Uwe Klaus Zettl
Current Pharmaceutical Design. 2021; 27
[Pubmed]  [Google Scholar] [DOI]
26 Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
Stefania Zampatti,Carlo Fabrizio,Michele Ragazzo,Giulia Campoli,Valerio Caputo,Claudia Strafella,Clelia Pellicano,Raffaella Cascella,Gianfranco Spalletta,Laura Petrosini,Carlo Caltagirone,Andrea Termine,Emiliano Giardina
Journal of Personalized Medicine. 2021; 11(9): 851
[Pubmed]  [Google Scholar] [DOI]
27 Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN® System Comprehensive Approach
Michela Roberto,Alessandro Rossi,Martina Panebianco,Leda Marina Pomes,Giulia Arrivi,Debora Ierinň,Maurizio Simmaco,Paolo Marchetti,Federica Mazzuca
Pharmaceuticals. 2021; 14(1): 67
[Pubmed]  [Google Scholar] [DOI]
28 Comparing Potential Drug–Drug Interactions in Companion Animal Medications Using Two Electronic Databases
Tussapon Boonyarattanasoonthorn,Phisit Khemawoot,Anusak Kijtawornrat
Veterinary Sciences. 2021; 8(4): 60
[Pubmed]  [Google Scholar] [DOI]
29 Assessing Consistency of Drug-Drug Interaction-Related Information Across Various Drug Information Resources
Atiqulla Shariff,Sathvik Belagodu Sridhar,Neelu Farhath Abdullah Basha,Shamma Sulaiman Hasan Bin Taleth Alshemeil,Noora Adel Ahmed Aljallaf Alzaabi
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
30 Investigation of Potential Drug-Drug Interactions in an Intensive Care Unit Using Lexicomp Drug Interactions
Hiroki Tateishi, Daisuke Miyazu, Takao Goto, Michiko Mukae, Yoshitoyo Miyauchi, Yoichi Koda, Hirokazu Tanaka, Masaaki Hirakawa
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 2020; 46(10): 576
[Pubmed]  [Google Scholar] [DOI]
31 The pharmacoepidemiology of potential drug-drug interactions in patients with psychiatric disorders
O. O. Kirilochev,A. R. Umerova
Kachestvennaya klinicheskaya praktika. 2020; (3): 85
[Pubmed]  [Google Scholar] [DOI]
32 Prevalence of Potential Drug–Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital
Gracia Santos-Díaz,Ana María Pérez-Pico,Miguel Ángel Suárez-Santisteban,Vanesa García-Bernalt,Raquel Mayordomo,Pedro Dorado
Pharmaceutics. 2020; 12(8): 713
[Pubmed]  [Google Scholar] [DOI]
33 Prevalence, predictors and outcomes of potential drug-drug interactions in left ventricular failure: considerable factors for quality use of medicines
Inamul Haq,Mohammad Ismail,Fahadullah Khan,Qasim Khan,Zahid Ali,Sidra Noor
Brazilian Journal of Pharmaceutical Sciences. 2020; 56
[Pubmed]  [Google Scholar] [DOI]
34 Patterns and characteristics of polypharmacy among elderly residents in Danish nursing homes
Jacob Astorp,Mimoza Gjela,Pernille Jensen,Rasmus D Bak,Parisa Gazerani
Future Science OA. 2020; : FSO590
[Pubmed]  [Google Scholar] [DOI]
35 Performance Assessment of Software to Detect and Assist Prescribers with Antimicrobial Drug Interactions: Are all of them Created Equal?
Elena Morte-Romea,Pilar Luque-Gómez,Mercedes Arenere-Mendoza,Jose Luis Sierra-Monzón,Ana Camón Pueyo,Galadriel Pellejero Sagastizabal,Guillermo Verdejo Muńoz,David Sánchez Fabra,José Ramón Pańo-Pardo
Antibiotics. 2020; 9(1): 19
[Pubmed]  [Google Scholar] [DOI]
36 Potential Drug interactions with Drugs used for Bipolar Disorder: A Comparison of 6 Drug Interaction Database Programs
Scott Monteith,Tasha Glenn,Michael Gitlin,Michael Bauer
Pharmacopsychiatry. 2020; 53(05): 220
[Pubmed]  [Google Scholar] [DOI]
37 Assessing Drug-Drug Interaction Potential among Patients Admitted to Surgery Departments in Three Palestinian Hospitals
Abdullah K. Rabba,Ayeshe M. Abu Hussein,Bayan K. Abu Sbeih,Somaya I. Nasser
BioMed Research International. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
38 Drug interactions of natural supplements in dermatology: a review
Edward K. Hadeler,Andrea D. Maderal
International Journal of Dermatology. 2020;
[Pubmed]  [Google Scholar] [DOI]
39 Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
Mohammad Ismail,Sehrash Khan,Fahadullah Khan,Sidra Noor,Hira Sajid,Shazia Yar,Irum Rasheed
BMC Cancer. 2020; 20(1)
[Pubmed]  [Google Scholar] [DOI]
40 Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness
Jayati Das-Munshi,Maya Semrau,Corrado Barbui,Neerja Chowdhary,Petra C. Gronholm,Kavitha Kolappa,Dzmitry Krupchanka,Tarun Dua,Graham Thornicroft
BMC Psychiatry. 2020; 20(1)
[Pubmed]  [Google Scholar] [DOI]
41 Enzymatic deinduction phenomenon and clinical implications with a focus on direct-acting oral anticoagulants
Jennifer L. Cole
Blood Coagulation & Fibrinolysis. 2020; 31(4): 283
[Pubmed]  [Google Scholar] [DOI]
42 Chronic Obstructive Pulmonary Disease: A palliative medicine review of the disease, its therapies and drug interactions
Andrea Weiss,Sandra Porter,Dmitry Rozenberg,Erin O’Connor,Tiffany Lee,Meyer Balter,Kirsten Wentlandt
Journal of Pain and Symptom Management. 2020;
[Pubmed]  [Google Scholar] [DOI]
43 Optimierung des Interaktionsmanagements zur Prävention potenzieller schwerwiegender Arzneimittelinteraktionen bei onkologischen Patienten
J. Rosentreter,A.-K. Engl,L. Wojnowski,M. Kühn,T. Wölfel,I. Krämer
best practice onkologie. 2020;
[Pubmed]  [Google Scholar] [DOI]
44 Prevalence of potential drug–drug interactions in outpatients on treatment with parenteral antineoplastic drugs
M. Castro-Manzanares,F. do Pazo-Oubińa,R. M. Rodríguez-Rincón
International Journal of Clinical Pharmacy. 2019;
[Pubmed]  [Google Scholar] [DOI]
45 Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients
Martin Klietz,Stephan Greten,Florian Wegner,Günter U. Höglinger
Drugs & Aging. 2019;
[Pubmed]  [Google Scholar] [DOI]
46 Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort
Guillaume Beinse,Delphine Reitter,Lauriane Segaux,Muriel Carvahlo-Verlinde,Benoit Rousseau,Christophe Tournigand,Tristan Cudennec,Marie Laurent,Pascaline Boudou-Rouquette,Elena Paillaud,Florence Canouď-Poitrine,Philippe Caillet
Journal of Geriatric Oncology. 2019;
[Pubmed]  [Google Scholar] [DOI]
47 The prevalence and severity of potential drug- drug interactions among polypharmacy patients in Jordan
Mohammad B. Nusair,Sayer I. Al-azzam,Rasha. M. Arabyat,Haneen A. Amawi,Karem H. Alzoubi,Asma Rabah
Saudi Pharmaceutical Journal. 2019;
[Pubmed]  [Google Scholar] [DOI]
48 A comparison of potential psychiatric drug interactions from six drug interaction database programs
Scott Monteith,Tasha Glenn
Psychiatry Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
49 Prevalence and trend of potential drug–drug interaction among children with depression in U.S. outpatient settings
L. Leanne Lai,Goar Alvarez,Linh Dang,Dung Vuong,Vy Ngo,Yailin Jo,Leroy Koh
Journal of Pharmaceutical Health Services Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
50 Comparison of potential drug-drug interactions with metabolic syndrome medications detected by two databases
Bovornpat Suriyapakorn,Pun Chairat,Suwanan Boonyoprakarn,Pimonwan Rojanarattanangkul,Wassana Pisetcheep,Natthaphon Hunsakunachai,Pornpun Vivithanaporn,Supakit Wongwiwatthananukit,Phisit Khemawoot,Masaki Mogi
PLOS ONE. 2019; 14(11): e0225239
[Pubmed]  [Google Scholar] [DOI]
51 Safety of psychopharmacotherapy: a clinical and pharmacological approach
O. O. Kirilochev,A. R. Umerova
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2019; 119(10): 127
[Pubmed]  [Google Scholar] [DOI]
52 Yogun Bakim Hastalarinda Antibiyotiklerin Diger Ilaçlarla Etkilesimlerinin Degerlendirilmesi
EMRE KARA,Kamer Tecen-Yücel,Nesligül Özdemir,Ahmet Çagkan Inkaya,Aygin Bayraktar-Ekincioglu,Kutay Demirkan,Serhat Ünal
STED / Sürekli Tip Egitimi Dergisi. 2019; : 404
[Pubmed]  [Google Scholar] [DOI]
53 Prediction of Drug-Drug Interactions Related to Inhibition or Induction of Drug-Metabolizing Enzymes
Alexander V. Dmitriev,Alexey A. Lagunin,Dmitry ?. Karasev,Anastasia V. Rudik,Pavel V. Pogodin,Dmitry A. Filimonov,Vladimir V. Poroikov
Current Topics in Medicinal Chemistry. 2019; 19(5): 319
[Pubmed]  [Google Scholar] [DOI]
54 Risk Factors for the Occurrence of Potential Drug-drug Interactions in Surgical Patients
Miloš N. Milosavljevic,Aleksandar G. Kocovic,Slobodan M. Jankovic,Dragce M. Radovanovic,Slobodan S. Milisavljevic,Srdan M. Stefanovic
Serbian Journal of Experimental and Clinical Research. 2019; 0(0)
[Pubmed]  [Google Scholar] [DOI]
55 Clozapine Patients at the Interface between Primary and Secondary Care
Marita Barrett,Anna Keating,Deirdre Lynch,Geraldine Scanlon,Mary Kigathi,Fidelma Corcoran,Laura Sahm
Pharmacy. 2018; 6(1): 19
[Pubmed]  [Google Scholar] [DOI]
56 Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Sidra Noor,Mohammad Ismail,Iqbal Haider,Faiza Khadim
Annals of Hepatology. 2018; 17(6): 1001
[Pubmed]  [Google Scholar] [DOI]
57 Risk factors for potential drug-drug interactions in intensive care unit patients
Slobodan M. Jankovic,Ana V. Pejcic,Miloš N. Milosavljevic,Valentina D. Opancina,Nikola V. Pešic,Tamara T. Nedeljkovic,Goran M. Babic
Journal of Critical Care. 2018; 43: 1
[Pubmed]  [Google Scholar] [DOI]
58 Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro
Leibin Shen,Jun Wang,Yongdong Yi,Chenmin Ye,Rongrong Wang,Guojun Xia,Chengyang Yu,Fuyang Tu,Jingxuan Xu,Zhiqiang Zheng
Drug Testing and Analysis. 2018;
[Pubmed]  [Google Scholar] [DOI]
59 Therapeutisches Drug-Monitoring (TDM) in der Praxis
Andreas von Heydwolff
psychopraxis. neuropraxis. 2018;
[Pubmed]  [Google Scholar] [DOI]
60 E-Health und die Realität – was sehen wir heute schon in der Klinik?
H. Gehring,K. Rackebrandt,M. Imhoff
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2018;
[Pubmed]  [Google Scholar] [DOI]
61 Prevalence of QT interval prolonging drug–drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study
Qasim Khan,Mohammad Ismail,Iqbal Haider,Fahadullah Khan
International Journal of Clinical Pharmacy. 2017;
[Pubmed]  [Google Scholar] [DOI]
62 Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study
Mohammad Ismail,Sana Aziz,Sidra Noor,Iqbal Haider,Faryal Shams,Inamul Haq,Faiza Khadim,Qasim Khan,Fahadullah Khan,Muhammad Asif
Journal of Critical Care. 2017; 40: 243
[Pubmed]  [Google Scholar] [DOI]

 

Read this article